BenevolentAI has 6 close competitors: Formation Bio, Insitro, Retro Biosciences.
Sector, valuation and status for each competitor.
company profile›
competitor›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
BenevolentAIFormation BioInsitroAtomwiseColossal BiosciencesEcovativa DesignAI platform for accelerating drug discovery and development
BenevolentAI competes with 6 companies here: Formation Bio, Insitro, Retro Biosciences, Atomwise, Colossal Biosciences, Ecovativa Design.
BenevolentAI was last valued at $2B (pre-money, Apr 2018). That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
No. BenevolentAI is a private company; its shares do not trade on a public exchange.
The last valuation is $2B.
Lead investors for each round are in the funding timeline.
The closest biotechnology/ai peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
